DUXAP8 and hepatocellular carcinoma: DUXAP8 downregulation notably increased malondialdehyde (MDA) production, the ratio between oxidized glutathione and reduced glutathione (GSSG/GSH ratio), and the ROS level all induced by sorafenib and erastin in HCC cells (Figure 3A–C).